26 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Mpltm1Wsa/Mpltm1Wsa Suz12Gt(Betageo)1Khe/Suz12+ involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
	thrombocytopenia	J:136262
Mpltm1Wsa/Mpltm1Wsa Suz12Plt8/Suz12+ B6.Cg-Mpltm1Wsa Suz12Plt8	abnormal bone marrow cell morphology/development	J:136262
	abnormal megakaryocyte differentiation	J:136262
	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
	thrombocytopenia	J:136262
Mpltm1Wsa/Mpltm1Wsa Suz12Plt8/Suz12Plt8 B6.Cg-Mpltm1Wsa Suz12Plt8	decreased embryo size	J:136262
	prenatal lethality, complete penetrance	J:136262
Mtf2tm1.1Hko/Mtf2tm1.1Hko Suz12tm1Hko/Suz12+ involves: C57BL/6	abnormal sternum morphology	J:170279
	cervical vertebral transformation	J:170279
	increased rib number	J:170279
	lumbar vertebral transformation	J:170279
	thoracic vertebral transformation	J:170279
	vertebral transformation	J:170279
Nf1tm1Tyj/Nf1+ Suz12Gt(Betageo)1Khe/Suz12+ involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6	abnormal melanocyte morphology	J:217077
	increased hepatocellular carcinoma incidence	J:217077
	increased histiocytic sarcoma incidence	J:217077
	increased intestinal adenoma incidence	J:217077
	increased lymphoma incidence	J:217077
	increased neurofibroma incidence	J:217077
	increased neurofibrosarcoma incidence	J:217077
	increased Schwannoma incidence	J:217077
	increased tumor incidence	J:217077
	premature death	J:217077
Nf1tm1Tyj/Nf1+ Suz12Gt(Betageo)1Khe/Suz12+ Trp53tm1Tyj/Trp53+ involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6	increased glioma incidence	J:217077
	increased hemangiosarcoma incidence	J:217077
	increased histiocytic sarcoma incidence	J:217077
	increased lymphoma incidence	J:217077
	increased neurofibrosarcoma incidence	J:217077
	increased tumor incidence	J:217077
	premature death	J:217077